RhumbLine Advisers’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $984K | Buy |
|
|||||
|
2025
Q2 | $725K | Sell |
|
|||||
|
2025
Q1 | $495K | Sell |
|
|||||
|
2024
Q4 | $753K | Buy |
|
|||||
|
2024
Q3 | $915K | Sell |
|
|||||
|
2024
Q2 | $655K | Buy |
|
|||||
|
2024
Q1 | $829K | Buy |
|
|||||
|
2023
Q4 | $533K | Sell |
|
|||||
|
2023
Q3 | $354K | Buy |
|
|||||
|
2023
Q2 | $403K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $208K | Buy |
|
|||||
|
2021
Q4 | $528K | Sell |
|
|||||
|
2021
Q3 | $760K | Buy |
|
|||||
|
2021
Q2 | $597K | Buy |
|
|||||
|
2021
Q1 | $551K | Buy |
|
|||||
|
2020
Q4 | $744K | Buy |
|
|||||
|
2020
Q3 | $217K | Sell |
|
|||||
|
2020
Q2 | $341K | Buy |
|